A recently published study by our group describes how radiotherapy promotes anti-tumour immunity increasing IL-21 and IL-23 cytokines and suppressing pro-tumourigenic pathways in the tumour microenvironment via downregulating the production of pro-angiogenic mediators (Donlon et al. 2022). Here, IL21 is linked to neoplasm.